Group II mGlu receptor agonists fail to protect against various neurotoxic insults induced in murine cortical, striatal and cerebellar granular pure neuronal cultures

Neuropharmacology

Volumn 41, Issue 1, 2001, Pages 19-31

  Moldrich, R X ^a   Giardina, S F ^a   Beart, P M ^a  

^a MONASH UNIVERSITY   (Australia)

Author keywords

cAMP; Cerebellum; Excitotoxicity; Group II metabotropic glutamate receptors; Neocortex; Neuronal cell culture; Striatum

Indexed keywords

2 (2,3 DICARBOXYCYCLOPROPYL)GLYCINE; 2 (CARBOXYCYCLOPROPYL)GLYCINE; 3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; 4 (4,4 DIPHENYLBUTYL)GLUTAMIC ACID; 4 AMINOPYRROLIDINE 2,4 DICARBOXYLATE; ALPHA AMINO 3 HYDROXY 5 METHYL 4 ISOXAZOLEPROPIONIC ACID; ANTIOXIDANT; BROMINE DERIVATIVE; CYCLIC AMP; EGLUMETAD; FORSKOLIN; HYDROGEN PEROXIDE; KAINIC ACID; METABOTROPIC RECEPTOR AGONIST; N ACETYLASPARTYLGLUTAMIC ACID; N METHYL DEXTRO ASPARTIC ACID; POTASSIUM ION; STAUROSPORINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CELL; BRAIN INJURY; CELL ACTIVATION; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG DETERMINATION; EMBRYO; GLIA CELL; IMMUNOCYTOCHEMISTRY; IN VITRO STUDY; MOUSE; NERVE CELL; NERVE CELL CULTURE; NERVE CELL MEMBRANE POTENTIAL; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; PHASE CONTRAST MICROSCOPE; PRIORITY JOURNAL; SECOND MESSENGER; STRIATE CORTEX; TOXICITY; TREATMENT FAILURE;

ALPHA-AMINO-3-HYDROXY-5-METHYL-4-ISOXAZOLEPROPIONIC ACID; ANIMALS; APOPTOSIS; CELL SURVIVAL; CELLS, CULTURED; CEREBELLUM; CEREBRAL CORTEX; CYCLIC AMP; EXCITATORY AMINO ACID AGONISTS; GLIAL FIBRILLARY ACIDIC PROTEIN; HYDROGEN PEROXIDE; IMMUNOHISTOCHEMISTRY; MICE; N-METHYLASPARTATE; NEOSTRIATUM; NEURONS; NEUROPROTECTIVE AGENTS; NEUROTOXINS; OXIDANTS; RECEPTORS, GLUTAMATE;

EID: 0034969126     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0028-3908(01)00045-4     Document Type: Article

References (64)

1. Characterization of t-butyl hydrogen peroxide toxicity in cultured rat cortical neurones and astrocytes
2. Specific group II glutamate receptor activation inhibits the development of kindled epilepsy in rats
3. Selective activation of group-II metabotropic glutamate receptors is protective against excitotoxic neuronal death
4. Immunohistochemistry with an antibody directed at mGluR3
5. Selective activation of group II mGluRs with LY354740 does not prevent neuronal excitotoxicity
6. LY379268, a potent and selective group II metabotropic glutamate receptor agonist, is neuroprotective in gerbil global, but not focal, cerebral ischemia
7. Protective effect of the metabotropic glutamate receptor agonist, DCG-IV, against excitotoxic neuronal death
8. Activation of class II or III metabotropic glutamate receptors protects cultured cortical neurons against excitotoxic degeneration
9. The neuroprotective activity of group-II metabotropic glutamate receptors requires new protein synthesis and involves a glial-neuronal signalling
10. Neuroprotection by glial metabotropic glutamate receptors is mediated by transforming growth factor-beta
11. Neuroprotective activity of N-acetylaspartylglutamate in cultured cortical cells
12. The inhibitory mGluR agonist, S-4-carboxyl-3-hydroxy-phenylglycine selectively attenuates NMDA neurotoxicity and oxygen-glucose deprivation-induced neuronal death
13. DCG-IV selectively attenuates rapidly triggered NMDA-induced neurotoxicity in cortical neurons
14. Metabotropic glutamate receptors and cell-type-specific vulnerability in the striatum: Implication for ischemia and Huntington's Disease
15. Effect of metabotropic glutamate receptor activation on receptor-mediated cyclic AMP responses in primary cultures of rat striatal neurones
16. Regulation of neurotransmitter release by metabotropic glutamate receptors
17. Dopaminergic modulation of NMDA-induced whole cell currents in neostriatal neurons in slices: Contribution of calcium conductances
18. Kainate-induced apoptosis correlates with c-Jun activation in cultured cerebellar granule cells
19. Micromolar L-glutamate induces extensive apoptosis in an apoptotic-necrotic continuum of insult-dependent, excitotoxic injury in cultured cortical neurones
20. Human Bcl-2 protects against AMPA receptor-mediated apoptosis
21. Immunohistochemical study on the distribution of the voltage-gated calcium alpha-1beta subunit in the mature rat brain
22. Activation of A(1) adenosine or mGlu3 metabotropic glutamate receptors enhances the release of nerve growth factor and S-100beta protein from cultured astrocytes
23. Excitatory synaptic transmission in neostriatal neurons, regulation by cyclic AMP-dependent mechanisms
24. Metabotropic glutamate receptor modulation of excitotoxicity in the neostriatum: Role of calcium channels
25. Pharmacology and functions of metabotropic glutamate receptors
26. Activation of metabotropic glutamate receptors protects against apoptosis induced by Beta-amyloid peptide
27. Astrocytes protect neurons from hydrogen peroxide toxicity
28. Induction of apoptosis in cerebellar granule neurons by low potassium: Inhibition of death by insulin-like growth factor I and cAMP
29. Neurons promote macrophage proliferation by producing transforming growth factor-beta2
30. Astrocyte-mediated enhancement of neuronal survival is abolished by glutathione deficiency
31. 2R,4R-4-aminopyrrolidine-2,4-dicarboxylate (APDC) attenuates cortical EPSPs
32. Bone morphogenetic protein-2 promotes survival and differentiation of striatal GABAergic neurons in the absence of glial cell proliferation
33. Role of metabotropic glutamate receptor in synaptic modulation in the accessory olfactory bulb
34. Apoptosis-inducing and -preventing signal transduction pathways in cultured cerebellar granule neurons
35. Agonists of cyclic AMP-coupled metabotropic glutamate receptors in adult-rat cortical slices
36. Neuroprotection by metabotropic glutamate receptor agonists: LY354740, LY379268 and LY389795
37. 1-Amino-APDC, a partial agonist of group II metabotropic glutamate receptors with neuroprotective properties
38. Excitatory amino acids as a final common pathway for neurologic disorders
39. Expression of type VI adenylyl cyclase in the central nervous system: Implication for a potential regulator of multiple signals in different neurotransmitter systems
40. Molecular characterization and localization of human metabotropic glutamate receptor type 3
41. Regulation of phosphoinositide turnover in neonatal rat cerebral cortex by group I- and II- selective metabotropic glutamate receptor agonists
42. Agonists for group II mGluRs and neurotoxicity in murine neuronal cultures
43. Low-affinity kainate receptor agonists induce insult-dependent apoptosis and necrosis in cultured murine cortical neurons
44. 2/3 agonist 2R,4R-4-aminopyrrolidine-2,4-dicarboxylate, is anti- and proconvulsant in DBA/2 mice
45. Metabotropic glutamate receptors: A new target for the therapy of neurodegenerative disorders
46. Distribution of the messenger RNA for a metabotropic glutamate receptor, mGluR2, in the central nervous system of the rat
47. Distribution of the mRNA for a metabotropic glutamate receptor (mGluR3) in the rat brain: An in situ hybridization study
48. Immunohistochemical localisation of metabotropic glutamate receptors, mGluR2 and mGluR3, in rat cerebellar cortex
49. Distribution of N-acetylaspartylglutamate immunoreactivity in human brain and its alteration in neurodegenerative disease
50. Excitatory amino acid release from rat hippocampal slices as a consequence of free-radical formation
51. Metabotropic G-protein-coupled glutamate receptors as therapeutic targets
52. Attenuation of excitatory amino acid toxicity by metabotropic glutamate receptor agonists and aniracetam in primary cultures of cerebellar granule cells
53. Activation of multiple metabotropic glutamate receptor subtypes prevents NMDA-induced excitotoxicity in rat hippocampal slices
54. Neuroprotection by metabotropic glutamate receptor agonists on kainate-induced degeneration of motor neurons in spinal cord slices from adult rat
55. Characterization of a metabotropic glutamate receptor: Direct negative coupling to adenylate cyclase and involvement of a pertussis toxin-sensitive G-protein
56. Pharmacological characterization of metabotropic glutamate receptors in several types of brain cells in primary cultures
57. Involvement of a cyclic-AMP pathway in group I metabotropic glutamate receptor responses in neonatal rat cortex
58. Selective inhibition of forskolin-stimulated cyclic AMP formation in rat hippocampus by a novel mGluR agonist, 2R,4R-4-aminopyrrolidine-2,4-dicarboxylate
59. The novel metabotropic glutamate receptor agonist (2R,4R)-APDC potentiates stimulation of phosphoinositide hydrolysis in the rat hippocampus by 3,5-dihydroxyphenyglycine: Evidence for a synergistic interaction between group 1 and group 2 receptors
60. Pharmacological agents acting at subtypes of metabotropic glutamate receptors
61. 3H]N-acetyl-aspartyl-glutamate (NAAG) binding sites in rat brain
62. Mechanisms of 1S,3R-ACPD-induced neuroprotection in rat hippocampal slices subjected to oxygen and glucose deprivation
63. Roles of metabotropic glutamate receptors in glial function and glial-neuronal communication
64. The expression of transforming growth factor-beta1 (TGF-B1) in hippocampal neurons: A temporary upregulated protein level after transient forebrain ischemia in the rat